Publications by authors named "Lassus Johan"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

5,609

Total Likes

863

Extended Reach

795,181

Social Features

231
V
Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score.
Elina Hynninen, Heli Tolppanen, Mercedes Rivas-Lasarte, Tuukka Tarvasmäki, Veli-Pekka Harjola, Johan Lassus

ESC Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels of miR-20b-5p are associated with survival in cardiogenic shock.
Tuomas Mäntylä, Chunguang Wang, Mikko Hänninen, Katariina Immonen, Toni Jäntti, Johan Lassus

J Mol Cell Cardiol Plus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials.
Sabri Soussi, Tuukka Tarvasmäki, Antoine Kimmoun, Mojtaba Ahmadiankalati, Feriel Azibani, Lassus Johan

EClinicalMedicine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
Jef Van den Eynde, Pieter Martens, Jeroen Dauw, Petra Nijst, Evelyne Meekers, Johan Lassus

Circ Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure.
Nikola Kozhuharov, Eleni Michou, Desiree Wussler, Maria Belkin, Corinna Heinisch, Johan Lassus

Biomedicines· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
Frederik H Verbrugge, Pieter Martens, Jeroen Dauw, Petra Nijst, Evelyne Meekers, Johan Lassus

J Am Coll Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment.
Hélène Nougué, Thibault Michel, François Picard, Johan Lassus, Malha Sadoune

Clin Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock.
Mari Hongisto, Johan Lassus, Tuukka Tarvasmäki, Jordi Sans-Roselló, Heli Tolppanen

Eur Heart J Acute Cardiovasc Care· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Wilfried Mullens, Jeroen Dauw, Pieter Martens, Evelyne Meekers, Petra Nijst, Johan Lassus

Eur J Heart Fail· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in cardiogenic shock.
Johan Lassus, Tuukka Tarvasmäki, Heli Tolppanen

Adv Clin Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
Wilfried Mullens, Pieter Martens, Jeffrey M Testani, W H Wilson Tang, Hadi Skouri, Johan Lassus

Eur J Heart Fail· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial.
Adriaan A Voors, Hillary Mulder, Eugene Reyes, Martin R Cowie, Johan Lassus

Eur J Heart Fail· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study.
Mari Hongisto, Johan Lassus, Tuukka Tarvasmäki, Alessandro Sionis, Jordi Sans-Rosello

ESC Heart Fail· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.
Mercedes Rivas-Lasarte, Jordi Sans-Roselló, Elena Collado-Lledó, Víctor González-Fernández, Francisco J Noriega, Johan Lassus

Eur Heart J Acute Cardiovasc Care· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
Toni Jäntti, Veli-Pekka Harjola, Mikko Haapio, Johan Lassus

Ann Intensive Care· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock.
Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, Kari Pulkki, Heidi Turkia, Johan Lassus

Ann Intensive Care· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study.
Anu Kataja, Tuukka Tarvasmäki, Johan Lassus, Alessandro Sionis, Alexandre Mebazaa

Int J Cardiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock.
Mikko Hänninen, Toni Jäntti, Heli Tolppanen, Heli Segersvärd, Tuukka Tarvasmäki, Johan Lassus

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology.
Veli-Pekka Harjola, John Parissis, Johann Bauersachs, Hans-Peter Brunner-La Rocca, Hector Bueno, Johan Lassus

Eur J Heart Fail· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney and liver dysfunction in cardiogenic shock.
Johan Lassus

Curr Opin Crit Care· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology.
Wilfried Mullens, Kevin Damman, Jeffrey M Testani, Pieter Martens, Christian Mueller, Johan Lassus

Eur J Heart Fail· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
Alexey A Konev, Alexey V Kharitonov, Fedor N Rozov, Evgeny P Altshuler, Daria V Serebryanaya, Johan Lassus

ESC Heart Fail· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions.
Justina Motiejūnaitė, Eiichi Akiyama, Alain Cohen-Solal, Aldo Pietro Maggioni, Christian Mueller, Johan Lassus

Eur Heart J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock.
Tuija Sabell, Marek Banaszewski, Johan Lassus, Markku S Nieminen, Heli Tolppanen

ESC Heart Fail· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis